Foghorn Therapeutics Inc.盘中异动大幅跳水6.42%报4.81美元

市场透视2025-09-19

北京时间2025年09月19日23时40分，Foghorn Therapeutics Inc.（FHTX.us）股票出现异动，股价大幅跳水6.42%。截至发稿，该股报4.81美元/股，成交量5.1221万股，换手率0.09%，振幅4.67%。最近的财报数据显示，该股实现营业收入7.56百万美元，净利润-17.94百万美元，每股收益-0.28美元，毛利6.66百万美元，市盈率-4.30倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2568297232?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-09-19 23:40","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2568297232","market":"us","top_or_hot":-1,"title":"Foghorn Therapeutics Inc.盘中异动 大幅跳水6.42%报4.81美元","media":"市场透视","content":"<div>\n<p>北京时间2025年09月19日23时40分，Foghorn Therapeutics Inc.（FHTX.us）股票出现异动，股价大幅跳水6.42%。截至发稿，该股报4.81美元/股，成交量5.1221万股，换手率0.09%，振幅4.67%。最近的财报数据显示，该股实现营业收入7.56百万美元，净利润-17.94百万美元，每股收益-0.28美元，毛利6.66百万美元，市盈率-4.30倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919234017979d7619&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Foghorn Therapeutics Inc.盘中异动 大幅跳水6.42%报4.81美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFoghorn Therapeutics Inc.盘中异动 大幅跳水6.42%报4.81美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-09-19 23:40 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919234017979d7619&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年09月19日23时40分，Foghorn Therapeutics Inc.（FHTX.us）股票出现异动，股价大幅跳水6.42%。截至发稿，该股报4.81美元/股，成交量5.1221万股，换手率0.09%，振幅4.67%。最近的财报数据显示，该股实现营业收入7.56百万美元，净利润-17.94百万美元，每股收益-0.28美元，毛利6.66百万美元，市盈率-4.30倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919234017979d7619&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919234017979d7619&s=b","article_id":"2568297232","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919234017979d7619&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2568297232","pubTimestamp":1758296417,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年09月19日23时40分，Foghorn Therapeutics Inc.股票出现异动，股价大幅跳水6.42%。截至发稿，该股报4.81美元/股，成交量5.1221万股，换手率0.09%，振幅4.67%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4539":"次新股","FHTX":"Foghorn Therapeutics Inc.","BK4139":"生物科技","LENZ":"Therapeutics","BK4007":"制药"},"translate_title":"Foghorn Therapeutics Inc. plunged 6.42% to $4.81 after intraday movements","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FHTX":1.5,"LENZ":1.5},"content_text":"北京时间2025年09月19日23时40分，Foghorn Therapeutics Inc.（FHTX.us）股票出现异动，股价大幅跳水6.42%。截至发稿，该股报4.81美元/股，成交量5.1221万股，换手率0.09%，振幅4.67%。最近的财报数据显示，该股实现营业收入7.56百万美元，净利润-17.94百万美元，每股收益-0.28美元，毛利6.66百万美元，市盈率-4.30倍。机构评级方面，在所有7家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 (To Pur Com)、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)涨幅较大，Clearmind Medicine Inc.、Adaptimmune Therapeutics Plc、Aptevo Therapeutics Inc.较为活跃，换手率分别为649.13%、152.73%、129.79%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025(To Pur Com)、Cdt Equity Inc C/Wts 22/09/2028(To Pur Com)，振幅分别为65.63%、35.29%、33.68%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。 其专有的基因流量控制平台对染色质调节系统的各个组成部分如何相互作用提供了一个综合的、机械的理解，使其能够识别、验证和潜在的系统内药物靶点。 该公司正在开发 FHD-286（一种选择性变构 ATP 酶抑制剂）和 FHD-609（一种蛋白质降解剂）， 用于治疗血液系统癌症和实体瘤。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2568297232","isCrawlerRequest":true}

Foghorn Therapeutics Inc.盘中异动 大幅跳水6.42%报4.81美元

精彩评论

Foghorn Therapeutics Inc.盘中异动大幅跳水6.42%报4.81美元